Meyahealth
HomeGeneticsConditionGiant axonal neuropathy
Back to Condition
Giant axonal neuropathy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Giant axonal neuropathy

Giant axonal neuropathy is an inherited condition characterized by abnormally large, dysfunctional nerve cell extensions called giant axons that lead to progressive neurological decline.

Overview

Giant axonal neuropathy is an inherited condition characterized by abnormally large and dysfunctional extensions of nerve cells (neurons) called giant axons. Axons are responsible for transmitting nerve impulses. Symptoms typically first appear in the peripheral nervous system, which connects the brain and spinal cord to muscles and sensory cells. However, axons in the central nervous system are also affected.

Symptoms

Signs and symptoms generally begin in early childhood and worsen over time. Common manifestations include:

  • Problems with walking
  • Loss of sensation, strength, and reflexes in the limbs
  • Difficulty coordinating movements (ataxia)
  • Requirement for wheelchair assistance
  • Abnormal curvature of the spine (scoliosis)
  • Visual and hearing problems
  • Extremely kinky hair
  • Autonomic nervous system issues, such as constipation, heat intolerance, neurogenic bladder, and reduced or lost ability to sweat

As the disorder progresses, individuals may experience paralysis, seizures, difficulty breathing or swallowing, and a gradual decline in mental function (dementia). Most people with this condition do not survive past their twenties. A milder form exists that begins later in life, progresses more slowly, and is often associated with straight hair and survival into adulthood.

Causes & Risk Factors

The condition is caused by mutations in the GAN gene, which provides instructions for making a protein called gigaxonin. Gigaxonin is part of the ubiquitin-proteasome system, which identifies and removes excess or damaged proteins. It specifically helps break down neurofilaments, which form the structural framework of axons.

Mutations result in unstable gigaxonin, leading to an accumulation of neurofilaments within axons. These densely packed neurofilaments prevent proper signal transmission and eventually cause the death of neurons.

Inheritance

Giant axonal neuropathy is inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell must have mutations. Parents of an affected individual each carry one copy of the mutated gene but typically do not show symptoms.

Frequently Asked Questions

For constipation, a high‑fiber diet, adequate hydration, and scheduled oral osmotic laxatives (e.g., polyethylene glycol) are first‑line. If refractory, a low‑dose stimulant laxative or rectal suppository may be added. Heat intolerance can be mitigated by staying in air‑conditioned environments, wearing cooling vests, and using frequent cool showers. Because reduced sweating raises the risk of hyperthermia, monitor core temperature during exercise and consider anticholinergic‑sparing strategies like evaporative cooling blankets.
multidisciplinary approach works best: (1) regular physical therapy focusing on gentle stretching, balance training, and use of orthoses; (2) occupational therapy for adaptive equipment (e.g., modified utensils, wheelchair with tilt‑in‑space features); (3) serial casting or night splints to maintain joint range; and (4) early referral to a pediatric neurologist for possible use of baclofen pumps or intrathecal agents to reduce spasticity.
Yes. Ongoing phase I/II trials are evaluating adeno‑associated virus (AAV) vectors delivering a functional GAN gene via intrathecal infusion. Additionally, small‑molecule chaperones that stabilize residual gigaxonin protein are in pre‑clinical testing. Families should monitor clinicaltrials.gov and discuss trial eligibility with a neuromuscular specialist.
Diagnosis combines clinical clues (early‑onset gait disturbance, kinky hair, sensory loss) with confirmatory genetic testing for pathogenic variants in the GAN gene. Nerve conduction studies show a mixed demyelinating‑and‑axonal pattern, and a skin or nerve biopsy can reveal characteristic giant axons, but genetic confirmation is now the gold standard.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ